Evidence map›Paper›PMID 32866536›Full record

ArticleVirus research2020

Association of vitamin D with the modulation of the disease severity in COVID-19.

R Mardani, A Alamdary, S D Mousavi Nasab, R Gholami, N Ahmadi, A Gholami

Open access · greenAbstract read
In one paragraph

Article in Virus research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 10 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 10 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.International journal of rheumatic diseases · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R MardaniViral Vaccines Production Unit, Pasteur Institute of Iran Production Complex, Tehran, Iran.
A AlamdaryViral Vaccines Production Unit, Pasteur Institute of Iran Production Complex, Tehran, Iran.
S D Mousavi NasabRotavaccine Research Lab, Pasteur Institute of Iran Production Complex, Tehran, Iran.
R GholamiShoushtar University of Medical Sciences, Shoushtar, Iran.
N AhmadiProteomics Research Center, Department of Medical Lab Technology, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: nayebalia@sbmu.ac.ir.
A GholamiViral Vaccines Production Unit, Pasteur Institute of Iran Production Complex, Tehran, Iran. Electronic address: a.gholami@pasteur.ac.ir.
Pasteur Institute of Iran · IRIslamic Azad University, Shoushtar Branch · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In late 2019, SARS-CoV-2 started to spread throughout the world causing the COVID-19 that has taken a considerable number of lives. Results obtained from several investigations have explained the virus origin, pathogenicity, and transmission. Similar to SARS coronavirus, the pulmonary angiotensin converting enzyme (ACE) 2 was introduced as the virus receptor for entering the cell. An increased body of epidemiological and clinical evidences has shown modulating effects of vitamin D in lung injuries through several mechanisms. Several clinical symptoms as well as molecular factors have shown to be related to the disease transmission and severity. In this study, vitamin D, ACE concentrations, and neutrophil to lymphocyte ratio (NLR) were measured in patients with confirmed COVID-19 in comparison with control group. Results demonstrated significant alterations in vitamin D and ACE levels as well as NLR in the patients' group. Contribution of those factors with the prognosis and severity of the disease has been shown.

Indexed as

BetacoronavirusPandemicsAdolescentAdultAgedCoronavirus InfectionsCOVID-19Disease ProgressionFemaleHumansLeukocyte CountLymphocyte CountMaleMiddle AgedNeutrophilsPeptidyl-Dipeptidase APeptidyl-Dipeptidase AVitamin DAngiotensin converting enzymeCOVID-19Vitamin D

Identifiers

PMID32866536
PMCPMC7455115
OpenAlexW3081140618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.